Physician profile
Beth Jordan
NPI 1548222433
$1,571.10
in general payments reported to CMS, 2019-2025
23 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $310 · 2023: $416 · 2024: $240 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $432.64 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $194.34 | 2021-2025 | |
| Lilly USA, LLC | $142.37 | 2021-2025 | Mounjaro, Emgality, Jardiance |
| Amgen INC. | $121.06 | 2021-2024 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $110.82 | 2021-2025 | Gardasil 9, Vaxelis, M-M-R II |
| Phathom Pharmaceuticals, INC. | $80.10 | 2024-2025 | Voquezna |
| Astellas Pharma US INC | $78.17 | 2023-2024 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $61.79 | 2021-2025 | Airsupra, Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $53.71 | 2022 | |
| Pfizer INC. | $45.42 | 2022-2025 | |
| Biogen, INC. | $31.75 | 2021-2022 | |
| Exact Sciences Corporation | $25.07 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $24.41 | 2023 | Freestyle Libre 2 |
| Amarin Pharma, INC. | $23.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.68 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $19.76 | 2025 | Korlym |
| Sanofi Pasteur INC. | $19.23 | 2022 | |
| Glaxosmithkline, LLC. | $17.44 | 2022 | |
| Soleno Therapeutics, INC. | $16.66 | 2025 | Vykat Xr |
| E.R. Squibb & Sons, L.L.C. | $15.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.78 | 2022 | |
| Corium, LLC | $11.56 | 2023 | Azstarys |
| Janssen Pharmaceuticals, INC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.